1 / 8

Innovation Scorecard: Invention, Adoption and Diffusion

Innovation Scorecard: Invention, Adoption and Diffusion. David Webb PDIG Summer Symposium. Measuring innovation… Often a ‘fuzzy’ business. There is nothing worse than a sharp image of a fuzzy concept Ansel Adams. For private companies. The what? Return on innovation

donat
Télécharger la présentation

Innovation Scorecard: Invention, Adoption and Diffusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Innovation Scorecard:Invention, Adoption and Diffusion David Webb PDIG Summer Symposium

  2. Measuring innovation…Often a ‘fuzzy’ business There is nothing worse than a sharp image of a fuzzy concept AnselAdams

  3. For private companies • The what? • Return on innovation • Profit divided by investment in innovation • What about the how? • Scale • Success • Efficiency

  4. The fuzzy logic Dealing with approximate reasoning since 1965

  5. Innovation in the NHS • Accelerating adoption and diffusion • NICE compliance regime • Publication of local formularies • NICE Implementation Collaborative • Innovation Scorecard • Academic Health Science Networks • 15 designated • Medicines optimisation • Transparency

  6. Off the peg? • No central collection • Hospital medicine utilisation • Data handling • Trust purchase data • Gaps • Outsourcing • Homecare • Collaborative procurement • Breadth or detail • 97% rule • Population alignment • Case mix • Standardisation • Spreadsheet • 102 TAs • 76 medicines

  7. Experimental status • All things to all people? • Identifies where variation in adoption may exist • Data sets • ePACT • Pharmex (in volumes)with agreement of NPSG • Industry data • Denominators • 100,000 resident population • 100,000 FCE bed days

  8. Concept and execution • Catalysis • Refreshed publication • How could the Scorecard be improved? • Is there a better way to standardise the data? • What are the patient perspectives?

More Related